Search the RE article base
Contact Information
Twitter
My TweetsUseful Web Sites
Tag Archives: faux
Bayh-Dole Basics, 4: contractor comments
Bayh-Dole defines anyone on the other side of a funding agreement from a federal agency as a contractor. The term is arbitrary and misleading. Let’s look at both aspects. The standard patent rights clause requires the contractors that host federally … Continue reading
Posted in Bayh-Dole
Tagged (f)(2), 37 CFR 401.14(a), 37 CFR 401.9, Bayh-Dole, contractor, faux, predatory, small business, Stanford v Roche, subcontract
Comments Off on Bayh-Dole Basics, 4: contractor comments
Bayh-Dole’s Public Covenant, 4
The Faux Public Covenant in Bayh-Dole The government license forms an essential part of the public covenant on inventions arising from research or development supported in part by government funding. For the other parts of the public covenant, the patent … Continue reading
Posted in Bayh-Dole
Tagged faux, government market, have practiced, public covenant
Comments Off on Bayh-Dole’s Public Covenant, 4
The Biddle Report’s Perfectly Fine Assumptions
From time to time, I revisit territory. I wrote about this issue almost two years ago, now. I provide here a different angle that gets at the same point. Here’s Sean O’Connor proposing that a flawed assumption in the U.S. … Continue reading
Posted in Bayh-Dole, History, Policy, Stanford v Roche
Tagged assignment, assumption, Bayh-Dole, Biddle, faux, O'Connor
Comments Off on The Biddle Report’s Perfectly Fine Assumptions
A New Guide to Bayh-Dole–Outline Version
Here’s an alternative guide to Bayh-Dole and its doppleganger faux Bayh-Dole. There’s a whole book in here, but I’ve left out the chapter and verse documentation and the historical evidence and interviews and the like. This is not the version … Continue reading
The NIH’s complicity in faux Bayh-Dole and high drug prices
Here’s “A ’20-20′ View of Invention Reporting to the National Institutes of Health”–published by the NIH in 1995. 2. WHAT IS THE BAYH-DOLE ACT AND WHY IS IT IMPORTANT? The Bayh-Dole Act encourages researchers to patent and market their inventions … Continue reading
Posted in Bayh-Dole, History, Stanford v Roche
Tagged 20-20, Bayh-Dole, faux, inventor loathing, NIH
Comments Off on The NIH’s complicity in faux Bayh-Dole and high drug prices
Senator Bayh’s inventor-loathing faux Bayh-Dole Act
There has been plenty written about the practice lesson taught by the Supreme Court decision in Stanford v Roche. I’m dismayed how much of it shows no evidence of an awareness of the facts of the case and the primary … Continue reading
Posted in Bayh-Dole, Policy, Stanford v Roche
Tagged Bayh, Bayh-Dole, faux, inventor loathing, of, Stanford v Roche
1 Comment